https://www.marketscreener.com/quote/stock/CYCLACEL-PHARMACEUTICALS--11337534/news/Cyclacel-Reports-Updated-Data-From-Its-DNA-Damage-Response-Program-on-Seliciclib-and-Sapacitabine-Co-22479053/?utm_source=telegram&utm_medium=social&utm_campaign=share